Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]piperazine monomethanesulfonate (U-90152S), a second-generation clinical candidate.

Autor: Romero DL; Upjohn Laboratories, Kalamazoo, Michigan 49001., Morge RA, Genin MJ, Biles C, Busso M, Resnick L, Althaus IW, Reusser F, Thomas RC, Tarpley WG
Jazyk: angličtina
Zdroj: Journal of medicinal chemistry [J Med Chem] 1993 May 14; Vol. 36 (10), pp. 1505-8.
DOI: 10.1021/jm00062a027
Databáze: MEDLINE